Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Shortage reports
Actual shortage:
20 (3%)
Anticipated shortage:
6 (1%)
Avoided shortage:
88 (12%)
Resolved:
604 (84%)
718
Discontinuation Reports
To be discontinued:
0 (0%)
Discontinued:
235 (100%)
Reversed:
0 (0%)
235
89 (9%)
19 (73%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-INDAPAMIDE | 2.5MG | TABLET | Avoided shortage | 2017-04-19 | 2018-01-26 | 7289 |
| MYLAN-INDAPAMIDE | 2.5MG | TABLET | Resolved | 2019-02-15 | 2019-06-19 | 75945 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Avoided shortage | 2019-05-14 | 2019-05-28 | 84073 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2019-05-28 | 2019-08-14 | 84997 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2020-04-02 | 2020-06-17 | 110480 |
| MYLAN-IPRATROPIUM SOLUTION | 0.25MG | SOLUTION | Resolved | 2017-11-23 | 2018-07-05 | 30371 |
| MYLAN-IRBESARTAN | 150MG | TABLET | Resolved | 2017-05-05 | 2018-08-11 | 9203 |
| MYLAN-IRBESARTAN | 300MG | TABLET | Resolved | 2017-05-05 | 2017-10-03 | 9210 |
| MYLAN-IRBESARTAN | 75MG | TABLET | Resolved | 2017-05-05 | 2018-07-05 | 9217 |
| MYLAN-LAMOTRIGINE | 150MG | TABLET | Resolved | 2017-06-02 | 2018-03-20 | 11782 |
| MYLAN-LAMOTRIGINE | 25MG | TABLET | Resolved | 2023-06-21 | 2023-07-14 | 196047 |
| MYLAN-LAMOTRIGINE | 150MG | TABLET | Resolved | 2023-12-19 | 2024-01-19 | 213761 |
| MYLAN-LAMOTRIGINE | 150MG | TABLET | Resolved | 2025-01-28 | 2025-04-28 | 248758 |
| MYLAN-LAMOTRIGINE | 25MG | TABLET | Avoided shortage | 2018-01-19 | 2018-02-08 | 36703 |
| MYLAN-LAMOTRIGINE | 100MG | TABLET | Resolved | 2019-07-23 | 2019-08-23 | 89824 |
| MYLAN-LAMOTRIGINE | 25MG | TABLET | Resolved | 2020-04-07 | 2020-05-06 | 111260 |
| MYLAN-LAMOTRIGINE | 100MG | TABLET | Avoided shortage | 2020-04-07 | 2020-04-29 | 111263 |
| MYLAN-LAMOTRIGINE | 150MG | TABLET | Avoided shortage | 2020-04-15 | 2020-05-26 | 112220 |
| MYLAN-LAMOTRIGINE | 25MG | TABLET | Resolved | 2020-05-20 | 2020-05-26 | 115383 |
| MYLAN-LAMOTRIGINE | 150MG | TABLET | Resolved | 2020-06-03 | 2020-06-26 | 116446 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-SIMVASTATIN | 5MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94112 |
| MYLAN-SIMVASTATIN | 10MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94117 |
| MYLAN-SIMVASTATIN | 20MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94122 |
| MYLAN-SIMVASTATIN | 40MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94127 |
| MYLAN-SIMVASTATIN | 80MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94132 |
| MYLAN-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-06-06 | 2018-08-11 | 51618 |
| MYLAN-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-06-06 | 2018-08-11 | 51624 |
| MYLAN-TELMISARTAN HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6814 |
| MYLAN-TELMISARTAN HCTZ | 25MG 80MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6819 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155040 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155037 |
| MYLAN-TRAMADOL/ACET | 37.5MG 325MG | TABLET | Discontinued | 2017-04-13 | 2018-02-15 | 6822 |
| MYLAN-VALSARTAN | 40MG | TABLET | Discontinued | 2017-08-24 | 2018-07-04 | 20209 |
| MYLAN-VALSARTAN | 320MG | TABLET | Discontinued | 2017-08-24 | 2018-07-04 | 20217 |
| MYLAN-VALSARTAN | 160MG | TABLET | Discontinued | 2017-08-24 | 2017-11-02 | 20284 |
| MYLAN-VALSARTAN | 80MG | TABLET | Discontinued | 2018-04-04 | 2018-07-04 | 44919 |
| MYLAN-VALSARTAN HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6827 |
| MYLAN-VALSARTAN HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6833 |
| MYLAN-VALSARTAN HCTZ | 25MG 160MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6836 |
| MYLAN-VALSARTAN HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6841 |